On Tuesday, Aspen hosted South African President Cyril Ramaphosa at its sterile facility, where the company will be manufacturing the Johnson & Johnson Covid-19 vaccine. Johnson & Johnson has agreed to supply 250 million vaccines for Africa, with 30 million being for South Africa. Stephen Saad, CEO at Aspen joins CNBC Africa for more.